UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Phase III Study by the Norwegian Lung Cancer Study Group: Pemetrexed Plus Carboplatin Compared With Gemcitabine Plus Carboplatin As First-Line Chemotherapy in Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2009-07, Vol.27 (19), p.3217-3224

2009

Volltextzugriff (PDF)

Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial

Journal of clinical oncology, 2008-09, Vol.26 (26), p.4261-4267

2008

Volltextzugriff (PDF)

Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer

Acta oncologica, 2016-05, Vol.55 (5), p.591-597

2016

Volltextzugriff (PDF)

Low oxygen saturation and mortality in an adult cohort: the Tromsø study

BMC pulmonary medicine, 2015-02, Vol.15 (1), p.9-9, Article 9

2015

Volltextzugriff (PDF)

Predictors of oxygen saturation ≤95% in a cross-sectional population based survey

Respiratory medicine, 2012-11, Vol.106 (11), p.1551-1558

2012

Volltextzugriff (PDF)

Pulmonary Function in Long-Term Survivors of Testicular Cancer

Journal of clinical oncology, 2009-06, Vol.27 (17), p.2779-2786

2009

Volltextzugriff (PDF)

Cisplatin and Etoposide Regimen Is Superior to Cyclophosphamide, Epirubicin, and Vincristine Regimen in Small-Cell Lung Cancer: Results From a Randomized Phase III Trial With 5 Years’ Follow-Up

Journal of clinical oncology, 2002-12, Vol.20 (24), p.4665-4672

2002

Volltextzugriff (PDF)

Low FEV1, smoking history, and obesity are factors associated with oxygen saturation decrease in an adult population cohort

International journal of chronic obstructive pulmonary disease, 2014, Vol.9 (default), p.1225-1233

2014

Volltextzugriff (PDF)

Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer

Acta oncologica, 2016-11, Vol.55 (11), p.1349-1354

2016

Volltextzugriff (PDF)

Reduced pulmonary function is associated with lower levels of endogenous total and free testosterone. The Tromsø Study

European journal of epidemiology, 2007-02, Vol.22 (2), p.107-112

2007

Volltextzugriff (PDF)

How Do Elderly Poor Prognosis Patients Tolerate Palliative Concurrent Chemoradiotherapy for Locally Advanced Non–Small-Cell Lung Cancer Stage III? A Subset Analysis From a Clinical Phase III Trial

Clinical lung cancer, 2015-05, Vol.16 (3), p.183-192

2015

Volltextzugriff (PDF)

Hypofractionated Palliative Radiotherapy (17 Gy per two fractions) in Advanced Non–Small-Cell Lung Carcinoma Is Comparable to Standard Fractionation for Symptom Control and Survival: A National Phase III Trial

Journal of clinical oncology, 2004-03, Vol.22 (5), p.801-810

2004

Volltextzugriff (PDF)

Low [FEV.sub.1], smoking history, and obesity are factors associated with oxygen saturation decrease in an adult population cohort

International journal of chronic obstructive pulmonary disease, 2014-01, Vol.9, p.1225

2014

Volltextzugriff (PDF)

A prospective phase II study: High-dose pemetrexed as second-line chemotherapy in small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2009-01, Vol.63 (1), p.88-93

2009

Volltextzugriff (PDF)

Treatment outcome in performance status 2 advanced NSCLC patients administered platinum-based combination chemotherapy

Lung cancer (Amsterdam, Netherlands), 2008-11, Vol.62 (2), p.253-260

2008

Volltextzugriff (PDF)

A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 2000-03, Vol.27 (3), p.145-157

2000

Volltextzugriff (PDF)

Palliative Thoracic Radiotherapy in Locally Advanced Non-small Cell Lung Cancer: Can Quality-Of-Life Assessments Help in Selection of Patients for Short- or Long-Course Radiotherapy?

Journal of thoracic oncology, 2006-10, Vol.1 (8), p.816-824

2006

Volltextzugriff (PDF)

Chemotherapy and quality of life in NSCLC PS 2 patients

Acta oncologica, 2009, Vol.48 (7), p.1019-1025

2009

Volltextzugriff (PDF)

Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group

British journal of cancer, 2013-09, Vol.109 (6), p.1467-1475

2013

Volltextzugriff (PDF)

The tragedy at Kapp Thordsen, Spitsbergen, 1872–1873. Could lead poisoning have been the cause?

Polar record, 2010-07, Vol.46 (3), p.200-209

2010

Volltextzugriff (PDF)

Lead Poisoning at the Swedish House

BMJ (British Medical Journal), 2009-12, Vol.339 (7735), p.1404-1405

2009

Volltextzugriff (PDF)

Multicenter Phase II Trial of Paclitaxel, Cisplatin, and Etoposide With Concurrent Radiation for Limited-Stage Small-Cell Lung Cancer

Journal of clinical oncology, 2001-08, Vol.19 (15), p.3532-3538

2001

Volltextzugriff (PDF)

Predictors of SpO2 ≤95% in a cross-sectional population based survey

Respiratory medicine, 2013-11, Vol.107 (11), p.S6-S6

2013

Volltextzugriff (PDF)

Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group

British journal of cancer, 2012-07, Vol.107 (3), p.442-447

2012

Volltextzugriff (PDF)

The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up

Lung cancer (Amsterdam, Netherlands), 2003-03, Vol.39 (3), p.303-313

2003

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(56)
Reviews
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(37)
Male
(33)
Aged
(32)
Middle Aged
(32)
Science & Technology
(31)
Life Sciences & Biomedicine
(30)
Female
(27)
Adult
(22)
Biological And Medical Sciences
(21)
Medical Sciences
(21)
Oncology
(21)
Aged, 80 And Over
(14)
Lung Neoplasms - Drug Therapy
(14)
Pneumology
(11)
Quality Of Life
(11)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)
Tumors Of The Respiratory System And Mediastinum
(10)
Lung Neoplasms - Mortality
(9)
Lung Neoplasms - Radiotherapy
(9)
Tumors
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase III Study by the Norwegian Lung Cancer Study Group: Pemetrexed Plus Carboplatin Compared With Gemcitabine Plus Carboplatin As First-Line Chemotherapy in Advanced Non–Small-Cell Lung Cancer

Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial

Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer

Low oxygen saturation and mortality in an adult cohort: the Tromsø study

Predictors of oxygen saturation ≤95% in a cross-sectional population based survey

Pulmonary Function in Long-Term Survivors of Testicular Cancer

Cisplatin and Etoposide Regimen Is Superior to Cyclophosphamide, Epirubicin, and Vincristine Regimen in Small-Cell Lung Cancer: Results From a Randomized Phase III Trial With 5 Years’ Follow-Up

Low FEV1, smoking history, and obesity are factors associated with oxygen saturation decrease in an adult population cohort

Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer

Reduced pulmonary function is associated with lower levels of endogenous total and free testosterone. The Tromsø Study

How Do Elderly Poor Prognosis Patients Tolerate Palliative Concurrent Chemoradiotherapy for Locally Advanced Non–Small-Cell Lung Cancer Stage III? A Subset Analysis From a Clinical Phase III Trial

Hypofractionated Palliative Radiotherapy (17 Gy per two fractions) in Advanced Non–Small-Cell Lung Carcinoma Is Comparable to Standard Fractionation for Symptom Control and Survival: A National Phase III Trial

Low [FEV.sub.1], smoking history, and obesity are factors associated with oxygen saturation decrease in an adult population cohort

A prospective phase II study: High-dose pemetrexed as second-line chemotherapy in small-cell lung cancer

Treatment outcome in performance status 2 advanced NSCLC patients administered platinum-based combination chemotherapy

A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC)

Palliative Thoracic Radiotherapy in Locally Advanced Non-small Cell Lung Cancer: Can Quality-Of-Life Assessments Help in Selection of Patients for Short- or Long-Course Radiotherapy?

Chemotherapy and quality of life in NSCLC PS 2 patients

Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group

The tragedy at Kapp Thordsen, Spitsbergen, 1872–1873. Could lead poisoning have been the cause?

Lead Poisoning at the Swedish House

Multicenter Phase II Trial of Paclitaxel, Cisplatin, and Etoposide With Concurrent Radiation for Limited-Stage Small-Cell Lung Cancer

Predictors of SpO2 ≤95% in a cross-sectional population based survey

Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group

The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up

Suchergebnisse filtern